z-logo
Premium
Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early‐onset breast cancer: Identification of three novel pathogenic mutations
Author(s) -
MartínezFerrandis J.I.,
Vega A.,
Chirivella I.,
MarínGarcía P.,
Insa A.,
Lluch A.,
Carracedo A.,
Chaves F.J.,
GarcíaConde J.,
Cervantes A.,
Armengod M.E.
Publication year - 2003
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.9188
Subject(s) - breast cancer , proband , missense mutation , biology , family history , genetics , ovarian cancer , population , genetic counseling , mutation , cancer , oncology , medicine , gene , environmental health
In Spain, the contribution of BRCA mutations to the population incidence of early‐onset breast cancer was unknown. We carried out a mutational analysis of the BRCA1 and BRCA2 genes in 124 Spanish women diagnosed with breast cancer before the age 41 and who were not selected for a family history of this disease. The genetic study was performed by PCR‐SSCP analysis and DNA sequencing. We identified 6 pathogenic BRCA mutations in 7 unrelated probands (5.6%; 95% CI=2.3% to 11.3%): 1 BRCA1 (c.2080delA) and 5 BRCA2 (p.Y3006X, p.Q1994X, c.9204_9217del14, c.9254_9258del5 and c.295+2T>C). Three out of 6 mutations were novel ( BRCA2 p.Y3006X, c.9204_9217del14, and c.295+2T>C), and two further mutations had not been previously found in Spain ( BRCA1 c.2080delA and BRCA2 p.Q1994X). The one remaining ( BRCA2 c.9254_9258del5) was detected in two probands of our sample. Additionally, we identified two new missense mutations: BRCA1 p.P1812A and BRCA2 p.G2044A. Our data support the notion that Spaniards represent a heterogeneous population with its own spectrum of BRCA mutations, some of which appear as founding mutations. We categorized patients into familial or non‐familial groups on the basis of her family history of breast/ovarian cancer; this analysis indicated that among Spanish women with early‐onset breast cancer, an even moderate family history is a good predictor of being a BRCA mutation carrier. © 2003 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here